Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?

Gynecologic Oncology

Volumn 115, Issue 3, 2009, Pages 453-455

  Khoury Collado, Fady ^a   Glaser, Gretchen E ^b   Zivanovic, Oliver ^a   Sonoda, Yukio ^a   Levine, Douglas A ^a   Chi, Dennis S ^a   Gemignani, Mary L ^a   Barakat, Richard R ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Blue dye injection; Endometrial cancer; Lymph node mapping; Sentinel lymph (SNL); Uterine cancer

Indexed keywords

TECHNETIUM 99M;

ARTICLE; CANCER SURGERY; DIAGNOSTIC PROCEDURE; ENDOMETRIUM CANCER; HISTOPATHOLOGY; LYMPH NODE DISSECTION; LYMPH NODE MAPPING; PRIORITY JOURNAL; SENTINEL LYMPH NODE; UTERINE CERVIX;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; METHYLENE BLUE; MIDDLE AGED; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM;

EID: 70350570491     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.08.026     Document Type: Article

References (11)

1. Abu-Rustum N.R., Khoury-Collado F., Pandit-Taskar N., Soslow R.A., Dao F., Sonoda Y., et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?. Gynecol. Oncol. 113 2 (2009) 163-169
2. Schwartz G.F., Giuliano A.E., Veronesi U., and the consensus conference committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Human Pathol. 33 (2002) 579-589
3. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127 (1992) 392-399
4. Morton D.L., Thompson J.F., Essner R., Elashoff R., Stern S.L., Nieweg O.E., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter selective lymphadenectomy trial group. Ann. Surg. 230 (1999) 453-463
5. Cody III H.S., Hill A.D., Tran K.N., Brennan M.F., and Borgen P.I. Credentialing for breast lymphatic mapping: how many cases are enough?. Ann. Surg. 229 (1999) 723-728
6. Levenback C.F., van der Zee A.G., Rob L., Plante M., Covens A., Schneider A., et al. Sentinel lymph node biopsy in patients with gynecologic cancers: expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol. Oncol. 114 2 (2009) 151-156
7. Li B., Li X.G., Wu L.Y., Zhang W.H., Li S.M., Min C., and Gao J.Z. A pilot study of sentinel lymph node identification in patients with endometrial cancer. Bull. Cancer 94 (2007) E1-E4
8. Frumovitz M., Bodurka D.C., Broaddus R.R., Coleman R.L., Sood A.K., Gershenson D.M., et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol. Oncol. 104 (2007) 100-103
9. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., and Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol. Oncol. 62 (1996) 169-173
10. Khoury-Collado F., and Abu-Rustum N.R. Lymphatic mapping in endometrial cancer: a literature review of current techniques and results. Int. J. Gynecol. Cancer 18 (2008) 1163-1168
11. Linehan D.C., Hill A.D., Akhurst T., Yeung H., Yeh S.D., Tran K.N., et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann. Surg. Oncol. 6 5 (1999) 450-454